MoneyWorks4Me

Novartis - Quaterly Results

10 May 2023 Evaluate
The sales is pegged at Rs. 761.30 millions for the March 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 983.20 millions during the year-ago period.The Total Profit for the quarter ended March 2023 of Rs. 250.20 millions grew from Rs.-233.70 millionsOperating Profit saw a handsome growth to 256.90 millions from 199.30 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 761.30 983.20 -22.57 3787.40 3998.70 -5.28 3787.40 3998.70 -5.28
Other Income 163.70 143.10 14.40 581.10 331.90 75.08 581.10 331.90 75.08
PBIDT 256.90 199.30 28.90 1231.90 603.00 104.30 1231.90 603.00 104.30
Interest 3.00 3.30 -9.09 17.50 48.30 -63.77 17.50 48.30 -63.77
PBDT 253.90 -300.40 -184.52 1214.40 58.30 1983.02 1214.40 58.30 1983.02
Depreciation 20.80 13.10 58.78 60.60 96.50 -37.20 60.60 96.50 -37.20
PBT 233.10 -313.50 -174.35 1153.80 -38.20 -3120.42 1153.80 -38.20 -3120.42
TAX -17.10 -79.80 -78.57 120.20 -1.00 -12120.00 120.20 -1.00 -12120.00
Deferred Tax 52.70 21.00 150.95 103.40 3.40 2941.18 103.40 3.40 2941.18
PAT 250.20 -233.70 -207.06 1033.60 -37.20 -2878.49 1033.60 -37.20 -2878.49
Equity 123.40 123.40 0.00 123.40 123.40 0.00 123.40 123.40 0.00
PBIDTM(%) 33.74 20.27 66.47 32.53 15.08 115.69 32.53 15.08 115.69
Peers